期刊
EXPERT REVIEW OF VACCINES
卷 11, 期 6, 页码 637-640出版社
EXPERT REVIEWS
DOI: 10.1586/ERV.12.33
关键词
cancer vaccines; clinical trials; E75; GP2; HER2/neu; li-Key hybrid peptides; multipeptide vaccines; safety